RenovoRx Inc (RNXT)

RenovoRx Inc (RNXT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $52.4M; returns 1 day +1.6%, 1 week +13.2%, 1 year +12.2%.

RenovoRx, Inc. is a life sciences company with a dual-track strategy focused on targeted oncology therapies. The company's sole source of revenue is the commercial sale of its patented, FDA-cleared RenovoCath® drug-delivery device, which enables its proprietary Trans-Arterial Micro-Perfusion (TAMP™) therapy platform.

Groups RNXT belongs to

• Healthcare
• Biotechnology
• Oncology
• Medical Devices
• Clinical Stage Biotech
• Pancreatic Cancer
• Cancer Therapeutics
• Life Sciences
• Precision Medicine

RNXT financial model: income statement, cash flow and balance sheet